By comparing the top 11 ranked lncRNAs with findings from other studies investigating differential expression (DE) between AF and EU prostate cancer patients, we identified five lncRNAs—AC098617.1, LINC00402, SLC8A1-AS1, AC005863.1, and LINC01001—that were consistently DE across all datasets, as shown in Table 3. This evidence concerns the gene SLC8A1 and prostate cancer.